Summary

The precision biotics market is estimated to record USD 4.91 billion in 2026 and reach USD 9.26 billion by 2031, at a CAGR of 13.5% from 2026 to 2031.

“Gut & brain segment is driving market growth due to the rising focus on the gut-brain axis and personalized mental wellness solutions”
The gut & brain sub-segment under health/functional positioning is expected to witness the fastest growth in the precision biotics market owing to the growing awareness about the gut-brain axis and rising cases of stress, anxiety, depression, and other mental conditions. The ongoing developments in microbiome science, growing scientific evidence of the impact of gut microbiota on brain function, and the need for tailored solutions for improving mental wellness are leading to the rising use of precision biotics for gut and brain health.
“E-commerce is driving market growth through expanding online retail and digital health platforms”
E-commerce is expected to become the fastest-growing route for distribution within the precision biotics market owing to the rising online purchasing trends and consumers' growing inclination toward easily available precision biotics products online. The development of online pharmacies, health and wellness platforms, as well as personalized offerings and recommendations, makes precision biotics more readily available, while competitive prices, broad product availability, and delivery at home keep boosting sales online.
“North America is expected to hold a significant share in the global precision biotics market owing to its advanced microbiome research ecosystem & strong industry presence”
North America holds the major share in the precision biotics market owing to the well-developed research ecosystem for microbiome, the presence of prominent precision biotics firms, and the use of personalized nutrition and preventive healthcare. Some other factors that contribute to the success of North America include the established healthcare infrastructure, rising awareness among consumers about gut health, innovations in microbiome, and access to clinically tested precision biotics.
In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the Precision Biotics market.
・By Company Type: Tier 1 – 30%, Tier 2 – 25%, and Tier 3 – 45%
・By Designation: CXOs – 25%, Managers – 35%, Others – 40%
・By Region: North America – 20%, Europe – 30%, Asia Pacific – 35%, and Rest of the World – 5%
Prominent companies in the market include BioGaia (Sweden), Novonesis Group (Denmark), Procter & Gamble (US), Unilever (UK), dsm-firmenich (Switzerland), Metagenics, LLC (US), Yakult Honsha Co., Ltd (Japan), Danone (France), KANEKA CORPORATION (Japan), Symrise (Germany)- (Probi), Jarrow Formulas, Inc (US), Pendulum (US), thegoodbug (India), Seed Health, Inc (US), Infinant Health Inc (US), and others.
Research Coverage
This research report categorizes the precision biotics market by type (precision probiotics, next generation probiotics (NGPs), synbiotics, postbiotics), end-use industry (dietary supplements, functional food & beverages, pet supplements, pharmaceutical (OTC), infant formula, cosmetics, animal feed), health/functional positioning (digestive & gastrointestinal health, women's health, pediatric & infant health, skin health, gut & brain health, metabolic health, immune health, oral & dental health), distribution channel (pharmacies, retail, specialty stores, e-commerce, DTC subscription platforms), and region (North America, Europe, Asia Pacific, Rest of the World).
The report’s scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, that influence the growth of the Precision Biotics industry. A thorough analysis of the key industry players has been done to provide insights into their business, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments associated with the Precision Biotics market. This report provides a competitive analysis of emerging startups in the Precision Biotics market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others.
Reasons to Buy This Report
The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall precision biotics and its subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following pointers:
・Analysis of key drivers (Growing Adoption of Personalized & Targeted Nutrition and Microbiome-based Healthcare, Growing Incidence of Gastrointestinal Disorders), restraints (High Development Costs of Strain-Specific Precision Biotics, Complex Regulatory Pathways for Personalized Microbiome Products), opportunities (Increasing Partnerships Between Biotech Firms and Healthcare Providers, Rising Demand for Precision Nutrition in Chronic Disease Management), and challenges (Ensuring Strain Stability and Product Quality Across Supply Chains, Need for Robust Clinical Evidence to Support Health Claims)
・Product Development/Innovation: Detailed insights into research & development activities and product launches in the precision biotics market
・Market Development: Comprehensive information about lucrative markets—analysis of precision biotics across varied regions
・Market Diversification: Exhaustive information about product sources, untapped geographies, recent developments, and investments in the precision biotics market
・Competitive Assessment: In depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as Darling Ingredients (US), Tessenderlo Group (Belgium) - BioGaia (Sweden), Novonesis Group (Denmark), Procter & Gamble (US), Unilever (UK), dsm-firmenich (Switzerland), Metagenics, LLC (US), Yakult Honsha Co., Ltd (Japan), Danone (France), KANEKA CORPORATION (Japan), Symrise (Germany)-(Probi), Jarrow Formulas, Inc (US), Pendulum (US), thegoodbug (India), Seed Health, Inc (US), Infinant Health Inc (US), and other players in the precision biotics market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 27
1.1 STUDY OBJECTIVES 27
1.2 MARKET DEFINITION 27
1.3 STUDY SCOPE AND SEGMENTATION 28
1.3.1 YEARS CONSIDERED 30
1.3.2 CURRENCY CONSIDERED 30
1.3.3 UNIT CONSIDERED 31
1.4 STAKEHOLDERS 31
2 EXECUTIVE SUMMARY 33
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 33
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 34
2.3 DISRUPTIVE TRENDS IN PRECISION BIOTICS MARKET 35
2.4 HIGH-GROWTH SEGMENTS 36
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 37
3 PREMIUM INSIGHTS 39
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PRECISION BIOTICS MARKET 39
3.2 PRECISION BIOTICS MARKET, BY TYPE AND REGION 40
3.3 PRECISION BIOTICS MARKET, BY TOP THREE TYPES 40
3.4 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL 41
3.5 PRECISION BIOTICS MARKET, BY TOP FOUR HEALTH/ FUNCTIONAL POSITIONINGS 41
3.6 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY 42
3.7 PRECISION BIOTICS MARKET, BY COUNTRY 42
4 MARKET OVERVIEW 43
4.1 INTRODUCTION 43
4.2 MARKET DYNAMICS 44
4.2.1 DRIVERS 44
4.2.1.1 Growing adoption of personalized & targeted nutrition and microbiome-based healthcare 44
4.2.1.2 Growing incidence of gastrointestinal disorders 45
4.2.1.3 Growing consumer focus on preventive healthcare 46
4.2.2 RESTRAINTS 46
4.2.2.1 High development costs of strain-specific precision biotics 46
4.2.2.2 Complex regulatory pathways for personalized microbiome products 47
4.2.3 OPPORTUNITIES 48
4.2.3.1 Increasing partnerships between biotech firms and healthcare providers 48
4.2.3.2 Rising demand for precision nutrition in chronic disease management 48
4.2.3.3 Growing integration of AI and multi-omics technologies in product development & advancement in the microbiome sequencing 49
4.2.4 CHALLENGES 50
4.2.4.1 Ensuring strain stability and product quality across supply chains 50
4.2.4.2 Need for robust clinical evidence to support health claims 51
4.3 UNMET NEEDS AND WHITE SPACES 51
4.3.1 UNMET NEEDS IN PRECISION BIOTICS MARKET 51
4.3.2 WHITE SPACE OPPORTUNITIES 52
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 53
4.4.1 INTERCONNECTED MARKETS 53
4.4.2 CROSS-SECTOR OPPORTUNITIES 53
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 54
4.5.1 KEY MOVES AND STRATEGIC FOCUS 54
5 INDUSTRY TRENDS 55
5.1 PORTER’S FIVE FORCES ANALYSIS 55
5.1.1 INTENSITY OF COMPETITIVE RIVALRY 56
5.1.2 BARGAINING POWER OF SUPPLIERS 56
5.1.3 BARGAINING POWER OF BUYERS 56
5.1.4 THREAT OF SUBSTITUTES 57
5.1.5 THREAT OF NEW ENTRANTS 57
5.2 MACROECONOMIC OUTLOOK 57
5.2.1 INTRODUCTION 57
5.2.2 MACROECONOMIC INDICATORS 57
5.2.2.1 Aging demographics fuel growth of north american probiotics market 57
5.2.2.2 Increasing national healthcare expenditure 58
5.2.2.3 Increasing prevalence of lifestyle-related chronic disorders 59
5.3 VALUE CHAIN ANALYSIS 59
5.3.1 RESEARCH & CONSUMER PRODUCT DEVELOPMENT 60
5.3.2 INGREDIENT SOURCING & STRAIN DEVELOPMENT 60
5.3.3 MANUFACTURING & PRODUCT FORMULATION 60
5.3.4 DISTRIBUTION, RETAIL & SUPPLY CHAIN MANAGEMENT 61
5.3.5 CONSUMER APPLICATIONS & COMMERCIALIZATION 61
5.4 ECOSYSTEM/MARKET MAP ANALYSES 61
5.4.1 DEMAND SIDE 61
5.4.2 SUPPLY SIDE 62
5.5 PRICING ANALYSIS 63
5.5.1 INTRODUCTION 63
5.5.2 INDICATIVE PRICE TREND AMONG MARKET PLAYERS 64
5.5.3 AVERAGE SELLING PRICE (ASP) TREND, BY REGION 64
5.5.4 AVERAGE SELLING PRICE (ASP) TREND BY TYPE, 2022–2025 (USD/TONS) 65
5.6 TRADE ANALYSIS 66
5.6.1 IMPORT ANALYSIS: PRECISION BIOTICS 67
5.6.2 EXPORT ANALYSIS: PRECISION BIOTICS 68
5.7 KEY CONFERENCES AND EVENTS, 2026–2027 68
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 69
5.9 INVESTMENT AND FUNDING SCENARIO 69
5.10 CASE STUDY ANALYSIS 70
5.10.1 PENDULUM – LAUNCH OF PENDULUM GLUCOSE CONTROL FOR PRECISION BLOOD SUGAR MANAGEMENT 70
5.10.2 BIOGAIA – LAUNCH OF BIOGAIA PROTECTIS PLUS NEXT-GENERATION PATENTED PROBIOTIC DROPS 71
5.10.3 FLORÉ (SUN GENOMICS) – DEVELOPMENT OF PRECISION SYNBIOTICS FOR AUTISM SPECTRUM DISORDER SUPPORT 71
5.10.4 VIOME – LAUNCH OF VRX MY·BIOTICS TOOTHPASTE & GEL FOR PERSONALIZED ORAL MICROBIOME HEALTH 72
5.11 IMPACT OF 2025 US TARIFF –PRECISION BIOTICS MARKET 73
5.11.1 INTRODUCTION 73
5.11.2 PRICE IMPACT ANALYSIS 74
5.11.3 IMPACT ON COUNTRIES/REGIONS 74
5.11.3.1 US 74
5.11.3.2 Europe 74
5.11.3.3 Asia Pacific 74
5.11.4 IMPACT ON END USE INDUSTRIES 75
6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 76
6.1 TECHNOLOGY ANALYSIS 76
6.1.1 KEY TECHNOLOGIES 76
6.1.1.1 Next-generation sequencing (NGS) 76
6.1.1.2 Precision fermentation & strain engineering 76
6.1.2 COMPLEMENTARY ANALYSIS 77
6.1.2.1 Microencapsulation & controlled release delivery systems 77
6.1.2.2 Synbiotic formulation technologies 77
6.1.3 ADJACENT TECHNOLOGIES 78
6.1.3.1 Bioprocess automation & smart manufacturing 78
6.1.3.2 Metabolomics platforms 78
6.2 PATENT ANALYSIS 79
6.3 FUTURE APPLICATIONS 81
6.3.1 SMART (DISEASE-SENSING) PROBIOTICS: ENABLING THE NEXT GENERATION OF PRECISION BIOTICS 82
6.3.2 ENGINEERED LIVE BIOTHERAPEUTICS: SHAPING THE FUTURE OF PRECISION BIOTICS 82
6.3.3 ENGINEERED PRECISION PROBIOTICS FOR INFLAMMATORY BOWEL DISEASE (IBD): ADVANCING TARGETED MICROBIOME THERAPEUTICS 83
6.3.4 POSTBIOTICS FOR NEXT-GENERATION FUNCTIONAL FOODS AND BIOPRESERVATION 83
6.4 IMPACT OF GENERATIVE AI ON PRECISION BIOTICS MARKET 84
6.4.1 INTRODUCTION 84
6.4.2 TOP USE CASES AND MARKET POTENTIAL 84
6.4.3 BEST PRACTICES IN PRECISION BIOTICS INDUSTRY 84
6.4.4 CASE STUDIES OF AI IMPLEMENTATION IN THE PRECISION BIOTICS MARKET 85
6.4.5 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 85
6.4.6 CLIENTS’ READINESS TO ADOPT GENERATIVE AI FOR PRECISION BIOTICS 86
6.5 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 86
7 SUSTAINABILITY AND REGULATORY LANDSCAPE 87
7.1 REGIONAL REGULATIONS AND COMPLIANCE 87
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87
7.1.2 INDUSTRY STANDARDS 90
7.1.3 LABELING REQUIREMENTS AND CLAIMS 92
7.1.4 ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS 93
7.1.4.1 Enhanced strain traceability and clinical evidence requirements 93
7.1.4.2 Global harmonization of precision biotics regulations 93
7.1.4.3 Stricter clinical validation and health claim compliance 93
7.1.4.4 Digital traceability, AI-enabled quality monitoring, and compliance automation 93
7.1.4.5 Higher quality standards for live biotherapeutic and next-generation biotics 93
7.2 SUSTAINABILITY INITIATIVES 93
7.2.1 SUSTAINABLE SOURCING 94
7.2.2 CARBON FOOTPRINT REDUCTION INITIATIVES 94
7.2.3 CIRCULAR ECONOMY APPROACHES 95
7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 95
7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS 96
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 97
8.1 DECISION-MAKING PROCESS 97
8.2 KEY STAKEHOLDERS AND BUYING CRITERIA 98
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 98
8.2.2 BUYING CRITERIA 99
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 100
8.4 UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN 101
8.5 MARKET PROFITABILITY 103
8.6 REVENUE POTENTIAL 103
8.6.1 COST DYNAMICS 103
8.6.2 MARGIN OPPORTUNITIES, BY TYPE 105
9 PRECISION BIOTICS MARKET, BY TYPE 106
9.1 INTRODUCTION 107
9.2 PRECISION PROBIOTICS 109
9.2.1 PRECISION PROBIOTICS TO FUEL EXPANSION OF PRECISION BIOTICS MARKET 109
9.3 NEXT-GENERATION PROBIOTICS 110
9.3.1 NEXT-GENERATION PROBIOTICS DRIVING INNOVATION IN PRECISION BIOTICS MARKET 110
9.4 SYNBIOTICS 112
9.4.1 PERSONALIZED SYNBIOTICS DRIVING INNOVATION AND GROWTH IN PRECISION BIOTICS MARKET 112
9.5 POSTBIOTICS 114
9.5.1 COMMERCIALIZATION OF POSTBIOTIC PRODUCTS STRENGTHENING PRECISION BIOTICS MARKET 114
10 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY 116
10.1 INTRODUCTION 117
10.2 DIETARY SUPPLEMENTS 118
10.2.1 GROWING DIETARY SUPPLEMENT ADOPTION DRIVING GLOBAL PRECISION BIOTICS GROWTH 118
10.3 FUNCTIONAL FOOD & BEVERAGES 119
10.3.1 GROWING DEMAND FOR FUNCTIONAL FOODS DRIVING PRECISION BIOTICS ADOPTION 119
10.4 PET SUPPLEMENTS 121
10.4.1 RISING PET HUMANIZATION DRIVING PRECISION BIOTICS ADOPTION IN COMPANION ANIMAL NUTRITION 121
10.5 PHARMACEUTICALS (OTC) 122
10.5.1 GROWING OTC SELF-CARE TRENDS ACCELERATING PRECISION BIOTICS ADOPTION 122
10.6 INFANT FORMULA 123
10.6.1 EARLY-LIFE NUTRITION INNOVATION DRIVING PRECISION BIOTICS ADOPTION IN INFANT FORMULA 123
10.7 COSMETICS 124
10.7.1 GROWING INVESTMENT IN MICROBIOME-BASED BEAUTY DRIVING PRECISION BIOTICS ADOPTION 124
10.8 ANIMAL FEED 125
10.8.1 SUSTAINABLE ANIMAL NUTRITION DRIVING PRECISION BIOTICS ADOPTION 125
11 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL 126
11.1 INTRODUCTION 127
11.2 PHARMACIES 128
11.2.1 PHARMACIES ACCELERATING ADOPTION OF PRECISION BIOTICS ACROSS GLOBE 128
11.3 RETAIL 130
11.3.1 EXPANDING ORGANIZED RETAIL NETWORKS STRENGTHEN CONSUMER ACCESS TO PRECISION BIOTICS 130
11.4 SPECIALTY STORES 131
11.4.1 SPECIALTY HEALTH STORES ENHANCE CONSUMER ACCESS TO PRECISION BIOTICS GLOBALLY 131
11.5 E-COMMERCE 132
11.5.1 EXPANDING E-COMMERCE PLATFORMS ACCELERATE PRECISION BIOTICS ADOPTION GLOBALLY 132
11.6 DTC SUBSCRIPTION PLATFORMS 133
11.6.1 DIRECT-TO-CONSUMER (DTC) SUBSCRIPTION PLATFORMS EXPAND GLOBAL PRECISION BIOTICS ACCESSIBILITY 133
12 PRECISION BIOTICS MARKET, BY HEALTH/ FUNCTIONAL POSITIONING 135
12.1 INTRODUCTION 136
12.2 DIGESTIVE & GASTROINTESTINAL HEALTH 137
12.2.1 MICROBIOME-BASED DIGESTIVE & GASTROINTESTINAL HEALTH SOLUTIONS ACCELERATING MARKET GROWTH 137
12.3 WOMEN’S HEALTH 139
12.3.1 ADVANCING WOMEN'S HEALTH THROUGH PRECISION MICROBIOME INNOVATION 139
12.4 PEDIATRIC & INFANT HEALTH 140
12.4.1 PEDIATRIC & INFANT HEALTH DRIVING GROWTH OF PRECISION BIOTICS MARKET 140
12.5 SKIN HEALTH 141
12.5.1 GROWING BURDEN OF SKIN DISORDERS DRIVING GLOBAL PRECISION BIOTICS ADOPTION 141
12.6 GUT & BRAIN HEALTH 142
12.6.1 GROWING MENTAL HEALTH BURDEN ACCELERATING PRECISION BIOTICS ADOPTION THROUGH GUT–BRAIN AXIS 142
12.7 METABOLIC HEALTH 143
12.7.1 GROWING BURDEN OF DIABETES AND PREDIABETES ACCELERATING PRECISION BIOTICS ADOPTION 143
12.8 IMMUNE HEALTH 144
12.8.1 GROWING FOCUS ON PREVENTIVE IMMUNITY DRIVING GLOBAL PRECISION BIOTICS ADOPTION 144
12.9 ORAL & DENTAL HEALTH 145
12.9.1 GROWING FOCUS ON PREVENTIVE IMMUNITY DRIVING GLOBAL PRECISION BIOTICS ADOPTION 145
13 PRECISION BIOTICS MARKET, BY REGION 147
13.1 INTRODUCTION 148
13.2 NORTH AMERICA 150
13.2.1 US 155
13.2.1.1 Growing government investments, precision nutrition initiatives,
and strategic collaborations driving US precision biotics market 155
13.2.2 CANADA 156
13.2.2.1 Government investments, expanding genomics ecosystem and commercialization programs accelerating Canadian precision biotics market 156
13.3 EUROPE 158
13.3.1 GERMANY 162
13.3.1.1 Precision Biotics Market Driven by Clinical Research and Personalized Nutrition 162
13.3.2 UK 163
13.3.2.1 Increasing Burden of Gastrointestinal Disorders Fueling Precision Biotics Demand 163
13.3.3 FRANCE 164
13.3.3.1 Growing Consumer Awareness and Personalized Nutrition Supporting Precision Biotics 164
13.3.4 ITALY 165
13.3.4.1 Strong Dietary Supplement Adoption Accelerates Precision Biotics Market Growth in Italy 165
13.3.5 SPAIN 167
13.3.5.1 Growing precision medicine and microbiome research drive Spain's precision biotics market 167
13.3.6 REST OF EUROPE 168
13.4 ASIA PACIFIC 169
13.4.1 CHINA 175
13.4.1.1 Expanding nutritional supplements industry accelerating precision biotics adoption in China 175
13.4.2 INDIA 176
13.4.2.1 Rising consumer awareness of gut health and preventive healthcare drives precision biotics market growth 176
13.4.3 JAPAN 177
13.4.3.1 Growing pharmaceutical investments support Japan's precision biotics market 177
13.4.4 AUSTRALIA & NEW ZEALAND 178
13.4.4.1 Advanced life sciences research and preventive healthcare drive the Australia & New Zealand precision biotics market 178
13.4.5 REST OF ASIA PACIFIC 179
13.5 REST OF THE WORLD (ROW) 180
13.5.1 LATIN AMERICA 184
13.5.1.1 Rising obesity and metabolic disorders drive precision biotics market growth 184
13.5.2 MIDDLE EAST 185
13.5.2.1 Expanding pharmaceutical manufacturing and precision medicine drive precision biotics market growth 185
13.5.3 AFRICA 186
13.5.3.1 Rising awareness of gut health and personalized nutrition supports market growth 186
14 COMPETITIVE LANDSCAPE 188
14.1 OVERVIEW 188
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 188
14.3 REVENUE ANALYSIS, 2023–2025 191
14.4 MARKET SHARE ANALYSIS, 2025 192
14.5 COMPANY VALUATION AND FINANCIAL METRICS 194
14.5.1 COMPANY VALUATION 194
14.5.2 EV/EBITDA 195
14.6 BRAND COMPARISON ANALYSIS, BY TYPE 195
14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 197
14.7.1 STARS 197
14.7.2 EMERGING LEADERS 197
14.7.3 PERVASIVE PLAYERS 197
14.7.4 PARTICIPANTS 198
14.7.5 COMPANY FOOTPRINT: KEY PLAYERS 199
14.7.5.1 Regional footprint 200
14.7.5.2 Type footprint 201
14.7.5.3 Function footprint 202
14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 202
14.8.1 PROGRESSIVE COMPANIES 202
14.8.2 RESPONSIVE COMPANIES 203
14.8.3 DYNAMIC COMPANIES 203
14.8.4 STARTING BLOCKS 203
14.8.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2025 204
14.8.5.1 Detailed list of key startups/SMEs 204
14.8.5.2 Competitive benchmarking of key startups/SMEs 205
14.9 COMPETITIVE SCENARIO AND TRENDS 206
14.9.1 PRODUCT LAUNCHES 206
14.9.2 DEALS 207
15 COMPANY PROFILES 209
15.1 KEY PLAYERS 209
15.1.1 BIOGAIA 209
15.1.1.1 Business overview 209
15.1.1.2 Products/Solutions/Services offered 210
15.1.1.3 Recent developments 211
15.1.1.3.1 Product launches 211
15.1.1.3.2 Deals 211
15.1.1.4 MnM view 212
15.1.1.4.1 Key strengths 212
15.1.1.4.2 Strategic choices 212
15.1.1.4.3 Weaknesses & competitive threats 212
15.1.2 NOVONESIS GROUP 213
15.1.2.1 Business overview 213
15.1.2.2 Products/Solutions/Services offered 214
15.1.2.3 Recent developments 215
15.1.2.3.1 Deals 215
15.1.2.4 MnM view 216
15.1.2.4.1 Key strengths 216
15.1.2.4.2 Strategic choices 216
15.1.2.4.3 Weaknesses & competitive threats 216
15.1.3 PROCTER & GAMBLE 217
15.1.3.1 Business overview 217
15.1.3.2 Products/Solutions/Services offered 218
15.1.3.3 MnM view 219
15.1.3.3.1 Key strengths 219
15.1.3.3.2 Strategic choices 219
15.1.3.3.3 Weaknesses & competitive threats 219
15.1.4 UNILEVER 220
15.1.4.1 Business overview 220
15.1.4.2 Products/Solutions/Services offered 221
15.1.4.3 Recent developments 222
15.1.4.3.1 Product launches 222
15.1.4.4 MnM view 222
15.1.4.4.1 Key strengths 222
15.1.4.4.2 Strategic choices 222
15.1.4.4.3 Weaknesses & competitive threats 222
15.1.5 DSM-FIRMENICH GROUP (CULTURELLE) 223
15.1.5.1 Business overview 223
15.1.5.2 Products/Solutions/Services offered 224
15.1.5.2.1 Deals 225
15.1.5.3 MnM view 226
15.1.5.3.1 Key strengths 226
15.1.5.3.2 Strategic choices 226
15.1.5.3.3 Weaknesses & competitive threats 226
15.1.6 NESTLÉ (NESTLÉ HEALTH SCIENCE) 227
15.1.6.1 Business overview 227
15.1.6.2 Products/Solutions/Services offered 229
15.1.6.3 MnM view 229
15.1.7 METAGENICS, LLC 230
15.1.7.1 Business overview 230
15.1.7.2 Products/Solutions/Services offered 231
15.1.7.3 Recent developments 232
15.1.7.3.1 Deals 232
15.1.7.4 MnM view 232
15.1.8 YAKULT HONSHA CO., LTD. 233
15.1.8.1 Business overview 233
15.1.8.2 Products/Solutions/Services offered 234
15.1.8.3 Recent developments 235
15.1.8.3.1 Product launches 235
15.1.8.4 MnM view 235
15.1.9 DANONE 236
15.1.9.1 Business overview 236
15.1.9.2 Products/Solutions/Services offered 237
15.1.9.3 Recent developments 238
15.1.9.3.1 Deals 238
15.1.9.4 MnM view 238
15.1.10 KANEKA CORPORATION (AB-BIOTICS) 239
15.1.10.1 Business overview 239
15.1.10.2 Products/Solutions/Services offered 240
15.1.10.3 Recent developments 241
15.1.10.3.1 Product launches 241
15.1.10.4 MnM view 241
15.1.11 SYMRISE GROUP (PROBI): BUSINESS OVERVIEW 242
15.1.11.1 Products/Solutions/Services offered 243
15.1.11.2 MnM view 243
15.1.12 JARROW FORMULAS, INC 244
15.1.12.1 Business overview 244
15.1.12.2 Products/Solutions/Services offered 244
15.1.12.3 MnM view 245
15.1.13 PENDULUM 246
15.1.13.1 Business overview 246
15.1.13.2 Products/Solutions/Services offered 246
15.1.13.3 Recent developments 247
15.1.13.3.1 Product launches 247
15.1.13.4 MnM view 247
15.1.14 THE GOOD BUG 248
15.1.14.1 Business overview 248
15.1.14.2 Products/Solutions/Services offered 248
15.1.14.3 MnM view 249
15.1.15 SEED HEALTH INC 250
15.1.15.1 Business overview 250
15.1.15.2 Products/Solutions/Services offered 250
15.1.15.3 MnM view 251
15.2 OTHER PLAYERS 252
15.2.1 INFINANT HEALTH INC. 252
15.2.1.1 Business overview 252
15.2.1.2 Products/Solutions/Services offered 252
15.2.1.3 MnM view 253
15.2.2 VIOME LIFE SCIENCES, INC. 254
15.2.2.1 Business overview 254
15.2.2.2 Products/Solutions/Services offered 254
15.2.2.2.1 Product launches 255
15.2.2.3 MnM view 255
15.2.3 BLACKMORES 256
15.2.3.1 Business overview 256
15.2.3.2 Products/Solutions/Services offered 256
15.2.3.3 MnM view 257
15.2.4 LAYER ORIGIN NUTRITION 258
15.2.4.1 Business overview 258
15.2.4.2 Products/Solutions/Services offered 258
15.2.4.3 Recent developments 259
15.2.4.4 MnM view 259
15.2.5 RESBIOTIC 260
15.2.5.1 Business overview 260
15.2.5.2 Products/Solutions/Services offered 260
15.2.5.3 Recent developments 261
15.2.5.3.1 Product launches 261
15.2.5.4 MnM view 261
15.2.6 FITBIOMICS 262
15.2.7 FLORE INC 263
15.2.8 ZBIOTICS 264
15.2.9 BIOHM TECHNOLOGIES 265
15.2.10 MRO MARYRUTH, LLC. 266
16 RESEARCH METHODOLOGY 267
16.1 RESEARCH DATA 267
16.1.1 SECONDARY DATA 268
16.1.1.1 Key data from secondary sources 268
16.1.2 PRIMARY DATA 269
16.1.2.1 Key data from primary sources 269
16.1.2.2 Breakdown of primary profiles 270
16.1.2.3 Key insights from industry experts 271
16.2 MARKET SIZE ESTIMATION 271
16.2.1 TOP-DOWN APPROACH 272
16.2.2 SUPPLY-SIDE ANALYSIS 273
16.2.3 BOTTOM-UP APPROACH (DEMAND SIDE) 274
16.3 DATA TRIANGULATION AND MARKET BREAKUP 275
16.4 RESEARCH ASSUMPTIONS 276
16.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 277
17 ADJACENT AND RELATED MARKETS 278
17.1 INTRODUCTION 278
17.2 RESEARCH LIMITATIONS 278
17.3 PROBIOTIC SUPPLEMENTS MARKET 278
17.3.1 MARKET DEFINITION 278
17.3.2 MARKET OVERVIEW 279
17.4 PROBIOTICS MARKET 280
17.4.1 MARKET DEFINITION 280
17.4.2 MARKET OVERVIEW 280
18 APPENDIX 282
18.1 DISCUSSION GUIDE 282
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 288
18.3 CUSTOMIZATION OPTIONS 290
18.4 RELATED REPORTS 290
18.5 AUTHOR DETAILS 291

ページTOPに戻る

List of Tables/Graphs

TABLE 1 INCLUSIONS AND EXCLUSIONS 29
TABLE 2 USD EXCHANGE RATES, 2021–2025 31
TABLE 3 INTERCONNECTED MARKETS 53
TABLE 4 PRECISION BIOTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 56
TABLE 5 PRECISION BIOTICS MARKET: SUPPLY CHAIN (ECOSYSTEM) 63
TABLE 6 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TON) 65
TABLE 7 AVERAGE SELLING PRICE (ASP) TREND BY TYPE, 2022–2025 (USD/TONS) 66
TABLE 8 TOP IMPORTERS OF PRECISION BIOTICS, 2022–2025 (USD) 67
TABLE 9 TOP EXPORTERS OF PRECISION BIOTICS, 2022–2025 (USD) 68
TABLE 10 PRECISION BIOTICS MARKET: LIST OF KEY CONFERENCES
AND EVENTS, 2026–2027 68
TABLE 11 PATENTS PERTAINING TO PRECISION BIOTICS MARKET, 2021–2026 80
TABLE 12 TOP USE CASES AND MARKET POTENTIAL 84
TABLE 13 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES 84
TABLE 14 PRECISION BIOTICS MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION 85
TABLE 15 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 85
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 87
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 88
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 88
TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 89
TABLE 20 INTERNATIONAL: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 90
TABLE 21 INDUSTRY STANDARDS IN PRECISION BIOTICS MARKET 91
TABLE 22 LABELING REQUIREMENTS AND CLAIMS IN PRECISION BIOTICS MARKET 92
TABLE 23 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN PRECISION
BIOTICS MARKET 96
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT TYPES 99
TABLE 25 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES 100
TABLE 26 UNMET NEEDS IN PRECISION BIOTICS MARKET, BY APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN 102
TABLE 27 COST DYNAMICS IN PRECISION MARKET 104
TABLE 28 MARGIN OPPORTUNITIES IN PRECISION BIOTICS MARKET, BY TYPE 105
TABLE 29 PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 107
TABLE 30 PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 108
TABLE 31 PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (TON) 108
TABLE 32 PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (TON) 108
TABLE 33 PRECISION PROBIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION) 109
TABLE 34 PRECISION PROBIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION) 109
TABLE 35 PRECISION PROBIOTICS MARKET, BY REGION, 2022–2025 (TONS) 110
TABLE 36 PRECISION PROBIOTICS MARKET, BY REGION, 2026–2031 (TONS) 110
TABLE 37 NEXT-GENERATION PROBIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION) 111
TABLE 38 NEXT-GENERATION PROBIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION) 111
TABLE 39 NEXT-GENERATION PROBIOTICS MARKET, BY REGION, 2022–2025 (TONS) 111
TABLE 40 NEXT-GENERATION PROBIOTICS MARKET, BY REGION, 2026–2031 (TONS) 112
TABLE 41 SYNBIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION) 112
TABLE 42 SYNBIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION) 113
TABLE 43 SYNBIOTICS MARKET, BY REGION, 2022–2025 (TONS) 113
TABLE 44 SYNBIOTICS MARKET, BY REGION, 2026–2031 (TONS) 113
TABLE 45 POSTBIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION) 114
TABLE 46 POSTBOTICS MARKET, BY REGION, 2026–2031 (USD MILLION) 114
TABLE 47 POSTBIOTICS MARKET, BY REGION, 2022–2025 (TONS) 115
TABLE 48 POSTBOTICS MARKET, BY REGION, 2026–2031 (TONS) 115
TABLE 49 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2022–2025 (USD MILLION) 118
TABLE 50 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2026–2031 (USD MILLION) 118
TABLE 51 PRECISION BIOTICS MARKET IN DIETARY SUPPLEMENTS,
BY REGION, 2022–2025 (USD MILLION) 119
TABLE 52 PRECISION BIOTICS MARKET IN DIETARY SUPPLEMENTS,
BY REGION, 2026–2031 (USD MILLION) 119
TABLE 53 PRECISION BIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES,
BY REGION, 2022–2025 (USD MILLION) 120
TABLE 54 PRECISION BIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES,
BY REGION, 2026–2031 (USD MILLION) 120
TABLE 55 PRECISION BIOTICS MARKET IN PET SUPPLEMENTS, BY REGION,
2022–2025 (USD MILLION) 121
TABLE 56 PRECISION BIOTICS MARKET IN PET SUPPLEMENTS, BY REGION,
2026–2031 (USD MILLION) 121
TABLE 57 PRECISION BIOTICS MARKET IN PHARMACEUTICALS (OTC),
BY REGION, 2022–2025 (USD MILLION) 122
TABLE 58 PRECISION BIOTICS MARKET IN PHARMACEUTICALS (OTC),
BY REGION, 2026–2031 (USD MILLION) 122
TABLE 59 PRECISION BIOTICS MARKET IN INFANT FORMULA, BY REGION,
2022–2025 (USD MILLION) 123
TABLE 60 PRECISION BIOTICS MARKET IN INFANT FORMULA, BY REGION,
2026–2031 (USD MILLION) 123
TABLE 61 PRECISION BIOTICS MARKET IN COSMETICS, BY REGION,
2022–2025 (USD MILLION) 124
TABLE 62 PRECISION BIOTICS MARKET IN COSMETICS, BY REGION,
2026–2031 (USD MILLION) 124
TABLE 63 PRECISION BIOTICS MARKET IN ANIMAL FEED, BY REGION,
2022–2025 (USD MILLION) 125
TABLE 64 PRECISION BIOTICS MARKET IN ANIMAL FEED, BY REGION,
2026–2031 (USD MILLION) 125
TABLE 65 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL,
2022–2025 (USD MILLION) 128
TABLE 66 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL,
2026–2031 (USD MILLION) 128
TABLE 67 PRECISION BIOTICS MARKET FROM PHARMACIES, BY REGION,
2022–2025 (USD MILLION) 129
TABLE 68 PRECISION BIOTICS MARKET FROM PHARMACIES, BY REGION,
2026–2031 (USD MILLION) 129
TABLE 69 PRECISION BIOTICS MARKET FROM RETAIL, BY REGION,
2022–2025 (USD MILLION) 130
TABLE 70 PRECISION BIOTICS MARKET FROM RETAIL, BY REGION,
2026–2031 (USD MILLION) 130
TABLE 71 PRECISION BIOTICS MARKET FROM SPECIALTY STORES, BY REGION,
2022–2025 (USD MILLION) 131
TABLE 72 SPECIALTY STORES: PRECISION BIOTICS MARKET, BY REGION,
2026–2031 (USD MILLION) 132
TABLE 73 PRECISION BIOTICS MARKET FROM E-COMMERCE, BY REGION,
2022–2025 (USD MILLION) 133
TABLE 74 PRECISION BIOTICS MARKET FROM E-COMMERCE, BY REGION,
2026–2031 (USD MILLION) 133
TABLE 75 PRECISION BIOTICS MARKET FROM DTC SUBSCRIPTION PLATFORMS,
BY REGION, 2022–2025 (USD MILLION) 134
TABLE 76 PRECISION BIOTICS MARKET FROM DTC SUBSCRIPTION PLATFORMS,
BY REGION, 2026–2031 (USD MILLION) 134
TABLE 77 PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING,
2022–2025 (USD MILLION) 137
TABLE 78 PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING,
2026–2031 (USD MILLION) 137
TABLE 79 PRECISION BIOTICS MARKET FOR DIGESTIVE & GASTROINTESTINAL HEALTH,
BY REGION, 2022–2025 (USD MILLION) 138
TABLE 80 PRECISION BIOTICS MARKET FOR DIGESTIVE & GASTROINTESTINAL HEALTH,
BY REGION, 2026–2031 (USD MILLION) 138
TABLE 81 PRECISION BIOTICS MARKET FOR WOMEN’S HEALTH, BY REGION,
2022–2025 (USD MILLION) 139
TABLE 82 PRECISION BIOTICS MARKET FOR WOMEN’S HEALTH, BY REGION,
2026–2031 (USD MILLION) 139
TABLE 83 PRECISION BIOTICS MARKET FOR PEDIATRIC AND INFANT HEALTH,
BY REGION, 2022–2025 (USD MILLION) 141
TABLE 84 PRECISION BIOTICS MARKET FOR PEDIATRIC AND INFANT HEALTH,
BY REGION, 2026–2031 (USD MILLION) 141
TABLE 85 PRECISION BIOTICS MARKET FOR SKIN HEALTH, BY REGION,
2022–2025 (USD MILLION) 142
TABLE 86 PRECISION BIOTICS MARKET FOR SKIN HEALTH, BY REGION,
2026–2031 (USD MILLION) 142
TABLE 87 PRECISION BIOTICS MARKET FOR GUT & BRAIN HEALTH, BY REGION,
2022–2025 (USD MILLION) 143
TABLE 88 PRECISION BIOTICS MARKET FOR GUT & BRAIN HEALTH, BY REGION,
2026–2031 (USD MILLION) 143
TABLE 89 PRECISION BIOTICS MARKET FOR METABOLIC HEALTH, BY REGION,
2022–2025 (USD MILLION) 144
TABLE 90 PRECISION BIOTICS MARKET FOR METABOLIC HEALTH, BY REGION,
2026–2031 (USD MILLION) 144
TABLE 91 PRECISION BIOTICS MARKET FOR IMMUNE HEALTH, BY REGION,
2022–2025 (USD MILLION) 145
TABLE 92 PRECISION BIOTICS MARKET FOR IMMUNE HEALTH, BY REGION,
2026–2031 (USD MILLION) 145
TABLE 93 PRECISION BIOTICS MARKET FOR ORAL & DENTAL HEALTH,
BY REGION, 2022–2025 (USD MILLION) 146
TABLE 94 PRECISION BIOTICS MARKET FOR ORAL & DENTAL HEALTH,
BY REGION, 2026–2031 (USD MILLION) 146
TABLE 95 PRECISION BIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION) 149
TABLE 96 PRECISION BIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION) 149
TABLE 97 PRECISION BIOTICS MARKET, BY REGION, 2022–2025 (TON) 149
TABLE 98 PRECISION BIOTICS MARKET, BY REGION, 2026–2031 (TON) 149
TABLE 99 NORTH AMERICA: PRECISION BIOTICS MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 151
TABLE 100 NORTH AMERICA: PRECISION BIOTICS MARKET, BY COUNTRY,
2026–2031 (USD MILLION) 151
TABLE 101 NORTH AMERICA: PRECISION BIOTICS MARKET, BY TYPE,
2022–2025 (USD MILLION) 151
TABLE 102 NORTH AMERICA: PRECISION BIOTICS MARKET, BY TYPE,
2026–2031 (USD MILLION) 151
TABLE 103 NORTH AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (TON) 152
TABLE 104 NORTH AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (TON) 152
TABLE 105 NORTH AMERICA: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY,
2022–2025 (USD MILLION) 152
TABLE 106 NORTH AMERICA: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 153
TABLE 107 NORTH AMERICA: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2022–2025 (USD MILLION) 153
TABLE 108 NORTH AMERICA: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026–2031 (USD MILLION) 154
TABLE 109 NORTH AMERICA: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 154
TABLE 110 NORTH AMERICA: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION) 154
TABLE 111 US: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 156
TABLE 112 US: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 156
TABLE 113 CANADA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 157
TABLE 114 CANADA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 157
TABLE 115 EUROPE: PRECISION BIOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 158
TABLE 116 EUROPE: PRECISION BIOTICS MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 158
TABLE 117 EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 159
TABLE 118 EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 159
TABLE 119 EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (TON) 159
TABLE 120 EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (TON) 159
TABLE 121 EUROPE: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY,
2022–2025 (USD MILLION) 160
TABLE 122 EUROPE: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 160
TABLE 123 EUROPE: PRECISION BIOTICS MARKET, BY HEALTH & FUNCTIONAL POSITIONING, 2022–2025 (USD MILLION) 161
TABLE 124 EUROPE: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026–2031 (USD MILLION) 161
TABLE 125 EUROPE: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL,
2022–2025 (USD MILLION) 162
TABLE 126 EUROPE: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL,
2026–2031 (USD MILLION) 162
TABLE 127 GERMANY: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 163
TABLE 128 GERMANY: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 163
TABLE 129 UK: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 164
TABLE 130 UK: PRECISION BIOTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 164
TABLE 131 FRANCE: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 165
TABLE 132 FRANCE: PRECISION BIOTICS MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 165
TABLE 133 ITALY: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 166
TABLE 134 ITALY: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 166
TABLE 135 SPAIN: PRECISION BIOTICS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 167
TABLE 136 SPAIN: PRECISION BIOTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 167
TABLE 137 REST OF EUROPE: PRECISION BIOTICS MARKET, BY TYPE,
2022–2025 (USD MILLION) 168
TABLE 138 REST OF EUROPE: PRECISION BIOTICS MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 169
TABLE 139 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 170
TABLE 140 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY COUNTRY,
2026–2031 (USD MILLION) 171
TABLE 141 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 171
TABLE 142 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 171
TABLE 143 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (TON) 172
TABLE 144 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (TON) 172
TABLE 145 ASIA PACIFIC: PRECISION BIOTICS MARKET, END-USE INDUSTRY,
2022–2025 (USD MILLION) 172
TABLE 146 ASIA PACIFIC: PRECISION BIOTICS MARKET, END-USE INDUSTRY,
2026–2031 (USD MILLION) 173
TABLE 147 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2022–2025 (USD MILLION) 173
TABLE 148 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026–2031 (USD MILLION) 174
TABLE 149 ASIA PACIFIC: PRECISION BIOTICS MARKET, DISTRIBUTION CHANNEL,
2022–2025 (USD MILLION) 174
TABLE 150 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL,
2026–2031 (USD MILLION) 174
TABLE 151 CHINA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 175
TABLE 152 CHINA: PRECISION BIOTICS MARKET, BY TYPE 2026–2031 (USD MILLION) 175
TABLE 153 INDIA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 176
TABLE 154 INDIA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 176
TABLE 155 JAPAN: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 177
TABLE 156 JAPAN: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 178
TABLE 157 AUSTRALIA & NEW ZEALAND: PRECISION BIOTICS MARKET,
BY TYPE, 2022–2025 (USD MILLION) 178
TABLE 158 AUSTRALIA & NEW ZEALAND: PRECISION BIOTICS MARKET,
BY TYPE, 2026–2031 (USD MILLION) 179
TABLE 159 REST OF ASIA PACIFIC: PRECISION BIOTICS MARKET,
BY TYPE, 2022–2025 (USD MILLION) 179
TABLE 160 REST OF ASIA PACIFIC: PRECISION BIOTICS MARKET,
BY TYPE, 2026–2031 (USD MILLION) 180
TABLE 161 ROW: PRECISION BIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION) 180
TABLE 162 ROW: PRECISION BIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION) 181
TABLE 163 ROW: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 181
TABLE 164 ROW: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 181
TABLE 165 ROW: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (TON) 181
TABLE 166 ROW: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (TON) 182
TABLE 167 ROW: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY,
2022–2025 (USD MILLION) 182
TABLE 168 ROW: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 182
TABLE 169 ROW: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING,
2022–2025 (USD MILLION) 183
TABLE 170 ROW: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING,
2026–2031 (USD MILLION) 183
TABLE 171 ROW: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL,
2022–2025 (USD MILLION) 184
TABLE 172 ROW: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL,
2026–2031 (USD MILLION) 184
TABLE 173 LATIN AMERICA: PRECISION BIOTICS MARKET, BY TYPE,
2022–2025 (USD MILLION) 185
TABLE 174 LATIN AMERICA: PRECISION BIOTICS MARKET, BY TYPE,
2026–2031 (USD MILLION) 185
TABLE 175 MIDDLE EAST: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 186
TABLE 176 MIDDLE EAST: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 186
TABLE 177 AFRICA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 187
TABLE 178 AFRICA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 187
TABLE 179 OVERVIEW OF STRATEGIES ADOPTED BY KEY PRECISION BIOTICS MANUFACTURER 188
TABLE 180 PRECISION BIOTICS MARKET: DEGREE OF COMPETITION 193
TABLE 181 PRECISION BIOTICS MARKET: REGIONAL FOOTPRINT, 2025 200
TABLE 182 PRECISION BIOTICS MARKET: TYPE FOOTPRINT, 2025 201
TABLE 183 PRECISION BIOTICS MARKET: FUNCTION FOOTPRINT, 2025 202
TABLE 184 PRECISION BIOTIC MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2025 204
TABLE 185 PRECISION BIOTIC: COMPETITIVE BENCHMARKING OF
KEY STARTUPS/SMES, 2025 205
TABLE 186 PRECISION BIOTICS MARKET: PRODUCT LAUNCHES, NOVEMBER 2021–JUNE 2026 206
TABLE 187 PRECISION BIOTICS MARKET: DEALS, NOVEMBER 2021–JUNE 2026 207
TABLE 188 BIOGAIA: COMPANY OVERVIEW 209
TABLE 189 BIOGAIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 210
TABLE 190 BIOGAIA: PRODUCT LAUNCHES 211
TABLE 191 BIOGAIA: DEALS 211
TABLE 192 NOVONESIS GROUP: COMPANY OVERVIEW 213
TABLE 193 NOVONESIS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 214
TABLE 194 NOVONESIS GROUP: DEALS 215
TABLE 195 PROCTER & GAMBLE (P&G).: COMPANY OVERVIEW 217
TABLE 196 PROCTER & GAMBLE (P&G).: PRODUCTS/SOLUTIONS/SERVICES OFFERED 218
TABLE 197 UNILEVER: COMPANY OVERVIEW 220
TABLE 198 UNILEVER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 221
TABLE 199 UNILEVER: PRODUCT LAUNCHES 222
TABLE 200 DSM-FIRMENICH GROUP (CULTURELLE): COMPANY OVERVIEW 223
TABLE 201 DSM-FIRMENICH GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 224
TABLE 202 DSM-FIRMENICH GROUP (CULTURELLE): DEALS 225
TABLE 203 NESTLÉ: COMPANY OVERVIEW 227
TABLE 204 NESTLÉ: PRODUCTS/SOLUTIONS/SERVICES OFFERED 229
TABLE 205 METAGENICS LLC: COMPANY OVERVIEW 230
TABLE 206 METAGENICS LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 231
TABLE 207 METAGENICS LLC: DEALS 232
TABLE 208 YAKULT HONSHA CO., LTD.: COMPANY OVERVIEW 233
TABLE 209 YAKULT HONSHA CO., LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED 234
TABLE 210 YAKULT HONSHA CO., LTD: PRODUCT LAUNCHES 235
TABLE 211 DANONE: COMPANY OVERVIEW 236
TABLE 212 DANONE.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 237
TABLE 213 DANONE: DEALS 238
TABLE 214 KANEKA CORPORATION (AB-BIOTICS): COMPANY OVERVIEW 239
TABLE 215 KANEKA CORPORATION (AB-BIOTICS): PRODUCTS/SOLUTIONS/SERVICES OFFERED 240
TABLE 216 KANEKA CORPORATION (AB-BIOTICS): PRODUCT LAUNCHES 241
TABLE 217 SYMRISE GROUP (PROBI): COMPANY OVERVIEW 242
TABLE 218 SYMRISE GROUP (PROBI): PRODUCTS/SOLUTIONS/SERVICES OFFERED 243
TABLE 219 JARROW FORMULAS INC: COMPANY OVERVIEW 244
TABLE 220 JARROW FORMULAS INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 244
TABLE 221 PENDULUM: COMPANY OVERVIEW 246
TABLE 222 PENDULUM: PRODUCTS/SOLUTIONS/SERVICES OFFERED 246
TABLE 223 PENDULUM: PRODUCT LAUNCHES 247
TABLE 224 THE GOOD BUG: COMPANY OVERVIEW 248
TABLE 225 THE GOOD BUG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 248
TABLE 226 SEED HEALTH INC.: COMPANY OVERVIEW 250
TABLE 227 SEED HEALTH INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 250
TABLE 228 INFINANT HEALTH INC.: COMPANY OVERVIEW 252
TABLE 229 INFINANT HEALTH INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 252
TABLE 230 VIOME LIFE SCIENCES, INC.: COMPANY OVERVIEW 254
TABLE 231 VIOME LIFE SCIENCES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 254
TABLE 232 VIOME LIFE SCIENCES, INC: PRODUCT LAUNCHES 255
TABLE 233 BLACKMORES: COMPANY OVERVIEW 256
TABLE 234 BLACKMORES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 256
TABLE 235 LAYER ORIGIN NUTRITION: COMPANY OVERVIEW 258
TABLE 236 LAYER ORIGIN NUTRITION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 258
TABLE 237 RESBIOTIC: COMPANY OVERVIEW 260
TABLE 238 RESBIOTIC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 260
TABLE 239 RESTBIOTIC: PRODUCT LAUNCHES 261
TABLE 240 KEY DATA FROM PRIMARY SOURCES 269
TABLE 241 MARKETS ADJACENT TO PRECISION BIOTICS MARKET 278
TABLE 242 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2022–2025 (USD MILLION) 279
TABLE 243 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2026–2031 (USD MILLION) 279
TABLE 244 PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION) 280
TABLE 245 PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION) 281

FIGURE 1 MARKETS COVERED AND REGIONAL SCOPE 28
FIGURE 2 STUDY YEARS CONSIDERED 30
FIGURE 3 MARKET SCENARIO 33
FIGURE 4 PRECISION BIOTICS MARKET, 2022–2031 (USD BILLION) 34
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PRECISION BIOTICS
MARKET, 2022–JUNE 2026 34
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF PRECISION BIOTICS MARKET 35
FIGURE 7 PRECISION BIOTICS MARKET: HIGH-GROWTH SEGMENTS, 2026–2031 36
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 37
FIGURE 9 INCREASING CONSUMER FOCUS ON GUT HEALTH AND PREVENTIVE HEALTHCARE TO ACCELERATE GROWTH OPPORTUNITIES IN PRECISION BIOTICS MARKET 39
FIGURE 10 PRECISION PROBIOTICS TYPE SEGMENT AND NORTH AMERICA REGION TO ACCOUNT FOR LARGEST MARKET SHARES IN 2026 40
FIGURE 11 PRECISION PROBIOTICS TYPE SEGMENT TO LEAD MARKET IN 2026 40
FIGURE 12 PHARMACIES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026 41
FIGURE 13 DIGESTIVE & GASTROINTESTINAL HEALTH SEGMENT TO DOMINATE
MARKET IN 2026 41
FIGURE 14 DIETARY SUPPLEMENTS END-USE INDUSTRY SEGMENT TO DOMINATE
MARKET IN 2026 42
FIGURE 15 US TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026 42
FIGURE 16 PRECISION BIOTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 44
FIGURE 17 PRECISION BIOTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 55
FIGURE 18 NATIONAL HEALTH EXPENDITURE PER CAPITA IN US FROM 2020 TO 2024 58
FIGURE 19 PRECISION BIOTIC MARKET: VALUE CHAIN ANALYSIS 60
FIGURE 20 PRECISION BIOTICS MARKET ECOSYSTEM MAP 62
FIGURE 21 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TON) 65
FIGURE 22 IMPORT OF HS CODE 300249, BY KEY COUNTRY, 2022–2025 (USD) 66
FIGURE 23 EXPORT OF HS CODE 300249, BY KEY COUNTRY, 2022–2025 (USD) 67
FIGURE 24 TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS’ BUSINESSES 69
FIGURE 25 INVESTMENT AND FUNDING SCENARIO 69
FIGURE 26 NUMBER OF PATENTS GRANTED BETWEEN 2016 AND 2026 79
FIGURE 27 FUTURE APPLICATIONS 81
FIGURE 28 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 86
FIGURE 29 PRECISION BIOTICS MARKET DECISION-MAKING FACTORS 97
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT TYPES 99
FIGURE 31 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES 100
FIGURE 32 ADOPTION BARRIERS AND INTERNAL CHALLENGES 101
FIGURE 33 PRECISION BIOTICS MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION) 107
FIGURE 34 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY,
2026 VS. 2031 (USD MILLION) 117
FIGURE 35 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL,
2026 VS. 2031 (USD MILLION) 127
FIGURE 36 PRECISION BIOTICS MARKET, BY HEALTH & FUNCTIONAL POSITIONING,
2026 VS. 2031 (USD MILLION) 136
FIGURE 37 PRECISION BIOTICS MARKET, BY KEY COUNTRY, 2026–2031 (USD MILLION) 148
FIGURE 38 NORTH AMERICA: PRECISION BIOTICS MARKET SNAPSHOT 150
FIGURE 39 ASIA PACIFIC: PRECISION BIOTICS MARKET SNAPSHOT 170
FIGURE 40 REVENUE ANALYSIS FOR KEY COMPANIES, 2023–2025 (USD BILLION) 191
FIGURE 41 SHARE OF LEADING COMPANIES IN PRECISION BIOTICS MARKET, 2025 192
FIGURE 42 COMPANY VALUATION OF PRECISION BIOTICS MANUFACTURERS, 2025 194
FIGURE 43 EV/EBITDA OF KEY COMPANIES, 2025 195
FIGURE 44 BRAND/PRODUCT/SERVICE ANALYSIS, BY KEY PLAYERS OF
PRECISION BIOTICS MARKET 195
FIGURE 45 PRECISION BIOTICS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 198
FIGURE 46 PRECISION BIOTICS MARKET: COMPANY FOOTPRINT, 2025 199
FIGURE 47 PRECISION BIOTIC MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2025 203
FIGURE 48 BIOGAIA: COMPANY SNAPSHOT 210
FIGURE 49 NOVONESIS GROUP: COMPANY SNAPSHOT 214
FIGURE 50 PROCTER & GAMBLE (P&G): COMPANY SNAPSHOTS 218
FIGURE 51 UNILEVER: COMPANY SNAPSHOTS 221
FIGURE 52 DSM-FIRMENICH GROUP (CULTURELLE): COMPANY SNAPSHOT 224
FIGURE 53 NESTLÉ: COMPANY SNAPSHOT 228
FIGURE 54 YAKULT HONSHA CO., LTD: COMPANY SNAPSHOT 234
FIGURE 55 DANONE: COMPANY SNAPSHOT 237
FIGURE 56 AB-BIOTICS (SUBSIDIARY OF KANEKA COMPANY): COMPANY SNAPSHOT 239
FIGURE 57 SYMRISE GROUP (PROBI): SNAPSHOT 242
FIGURE 58 PRECISION BIOTICS MARKET: RESEARCH DESIGN 267
FIGURE 59 KEY DATA FROM SECONDARY SOURCES 268
FIGURE 60 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE,
DESIGNATION, AND REGION 270
FIGURE 61 KEY INSIGHTS FROM INDUSTRY EXPERTS 271
FIGURE 62 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 272
FIGURE 63 SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP 273
FIGURE 64 PRECISION BIOTICS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 274
FIGURE 65 DATA TRIANGULATION 275